GalNAc Disialyl Lc4 (Hexasaccharide)
General | Antibody | Glycoprotein | Glycolipid | Enzyme | Reference4 reference for EP0097
| sort by year ∧ ∨ | Reference detail |
|---|---|
| 1 | Ito A, Levery SB, Saito S, Satoh M, Hakomori S. A novel ganglioside isolated from renal cell carcinoma. J Biol Chem. 2001 May 18;276(20):16695-703 PMID: 11278988 |
2 | Saito S, Egawa S, Endoh M, Ueno S, Ito A, Numahata K, Satoh M, Kuwao S, Baba S, Hakomori S, Arai Y. RM2 antigen (beta1,4-GalNAc-disialyl-Lc4) as a new marker for prostate cancer. Int J Cancer. 2005 May 20;115(1):105-13 PMID: 15704108 |
3 | Ito A, Saito S, Masuko T, Oh-Eda M, Matsuura T, Satoh M, Nejad FM, Enomoto T, Orikasa S, Hakomori SI. Monoclonal antibody (5F3) defining renal cell carcinoma-associated antigen disialosyl globopentaosylceramide (V3NeuAcIV6NeuAcGb5), and distribution pattern of the antigen in tumor and normal tissues. Glycoconj J. 2001 Jun ;18(6):475-85 PMID: 12084983 |
4 | Saito S, Levery SB, Salyan ME, Goldberg RI, Hakomori S. Common tetrasaccharide epitope NeuAc alpha 2-->3Gal beta 1-->3(Neu-Ac alpha 2-->6)GalNAc, presented by different carrier glycosylceramides or O-linked peptides, is recognized by different antibodies and ligands having distinct specificities. J Biol Chem. 1994 Feb 25;269(8):5644-52 PMID: 7509790 |